ACIP recommendation for COVID booster for children

Translate to Spanish or other 102 languages!

“We applaud the Advisory Committee on Immunization Practices (ACIP) for their thoughtful deliberations and recommendation supporting that children ages 5-11 should receive a booster dose of the Pfizer-BioNTech COVID-19 vaccine, at least five months after completion of the primary series. Image or illustration purposes
“We applaud the Advisory Committee on Immunization Practices (ACIP) for their thoughtful deliberations and recommendation supporting that children ages 5-11 should receive a booster dose of the Pfizer-BioNTech COVID-19 vaccine, at least five months after completion of the primary series. Image or illustration purposes

Mega Doctor News

- Advertisement -
Gerald E. Harmon, MD
President, American Medical Association
Courtesy Image

The following statement is attributable to:
Gerald E. Harmon, MD
President, American Medical Association

“We applaud the Advisory Committee on Immunization Practices (ACIP) for their thoughtful deliberations and recommendation supporting that children ages 5-11 should receive a booster dose of the Pfizer-BioNTech COVID-19 vaccine, at least five months after completion of the primary series. Based on what we know from other age groups, vaccine effectiveness against SARS-CoV-2 infection declines over time and vaccine booster doses have been shown to increase protection against all outcomes. With the highly transmissible Omicron variant continuing to evolve, strengthened neutralizing antibodies from the booster dose provides an additional layer of protection.

“The scientific evidence is clear that the vaccines against COVID-19 are safe and remain effective in preventing hospitalization and severe disease. It is concerning that only one in three children between the ages of 5 and 11 in the United States have received two doses of the vaccine, in part because parents believe them to be at lower risk for severe disease than adults. But the Omicron variant brought about change that should alter that calculus. According to the Centers for Disease Control and Prevention (CDC), the highly transmissible variant not only sent more children to the hospital and ICU than previous waves, but children who were unvaccinated were twice as likely to be hospitalized as those were vaccinated.

- Advertisement -

“Against this backdrop, we continue to strongly urge those who are eligible to stay up to date on their COVID-19 vaccines, including booster doses, to protect themselves and their loved ones from severe complications, hospitalization, and death. We look forward to the deliberations of the FDA’s Vaccines and Related Biological Products Advisory Committee and the ACIP on COVID-19 vaccine for kids under the age of 5, as many families are anxiously awaiting a safe and effective vaccine for this population.”

“Anyone with questions about the vaccines should speak with their physician and review trusted resources, including getvaccineanswers.org.”

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Study Reveals Link Between Parent and Child Weight Is Mostly Genetic

The link between parents’ body mass index (BMI) and their children’s BMI in childhood is driven largely by genetic inheritance, rather than by any direct biological effects of parental weight during pregnancy, a new study suggests.

DHR Health Continues to Lead the Way in Treatment of Alzheimer’s Disease for the RGV

Two years after DHR Health announced it was the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved intravenous treatment for early Alzheimer’s disease, DHR Health continues to expand access to advanced Alzheimer’s care for patients in the Rio Grande Valley being now the only facility doing amyloid PET Scans, a diagnostic test to accurately diagnose Alzheimer’s disease. DHR Health also offers Kisunla, another FDA-approved intravenous treatment for early symptomatic Alzheimer’s disease.

The Genetic Armor Defeating Colorectal Cancer

A team of scientists from the Barbara Ann Karmanos Cancer Institute, Wayne State University, and institutions across the U.S., have published a landmark paper on the role of TGFBR1*6A, a naturally occurring genetic mutation in the TGFBR1 gene found in approximately 14 percent of the general population. Image for illustration purposes

Why CKM Syndrome Requires a Coordinated Care Point Person

When the term “cardiovascular-kidney-metabolic syndrome” was created in 2023 to define how heart disease, kidney disease, obesity and diabetes are connected, one goal was to help health professionals understand the benefits of working together.
- Advertisement -